Voltaren and Azor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Voltaren (diclofenac sodium) and Azor (amlodipine besylate; olmesartan medoxomil). Common drug interactions include arthralgia among females and headache among males.

The phase IV clinical study analyzes what interactions people have when they take Voltaren and Azor. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Voltaren?

Voltaren has active ingredients of diclofenac sodium. It is often used in arthritis. eHealthMe is studying from 82,346 Voltaren users. Check the latest studies of Voltaren.

What is Azor?

Azor has active ingredients of amlodipine besylate; olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 3,922 Azor users. Check the latest studies of Azor.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 29, 2026

13 people who take Voltaren and Azor together, and have interactions are studied.

Voltaren and Azor drug interactions.

What are the common drug interactions of Voltaren and Azor, by gender? *:

female:

  1. Arthralgia (joint pain)
  2. Chronic kidney disease
  3. Renal failure (kidney dysfunction)
  4. Vomiting
  5. Erythema (redness of the skin)
  6. Therapeutic response unexpected
  7. Abdominal pain upper
  8. Diarrhoea
  9. Hepatic enzyme increased
  10. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)

male:

  1. Headache (pain in head)
  2. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  3. Abdominal pain upper
  4. Arthralgia (joint pain)
  5. Back pain
  6. Decreased activity
  7. Dyspepsia (indigestion)
  8. Gait disturbance
  9. Gout (uric acid crystals building up in the body)
  10. Therapeutic response unexpected

What are the common drug interactions of Voltaren and Azor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abdominal pain upper
  2. Diarrhoea
  3. Gout (uric acid crystals building up in the body)
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Muscle spasms (muscle contraction)
  6. Oedema peripheral (superficial swelling)
  7. Retching (strong involuntary effort to vomit)
  8. Vomiting
  9. Weight decreased

50-59:

  1. Arthralgia (joint pain)
  2. Hepatic enzyme increased
  3. Knee arthroplasty

60+:

  1. Arthralgia (joint pain)
  2. Erythema (redness of the skin)
  3. Headache (pain in head)
  4. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  5. Therapeutic response unexpected
  6. Chronic kidney disease
  7. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  8. Nephrogenic anaemia (anaemia due to kidney disease)
  9. Renal failure (kidney dysfunction)
  10. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

What are the existing conditions these people have? *

  1. Pain: 4 people, 30.77%
  2. Stress And Anxiety: 3 people, 23.08%
  3. Depression: 3 people, 23.08%
  4. Diabetes: 3 people, 23.08%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 23.08%
  6. Hypersensitivity: 3 people, 23.08%
  7. Muscle Spasms (muscle contraction): 3 people, 23.08%
  8. Infection: 3 people, 23.08%
  9. Joint Pain: 3 people, 23.08%
  10. High Blood Cholesterol: 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Voltaren and Azor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Voltaren and Azor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Voltaren:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Azor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Voltaren and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Azor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on diclofenac sodium and amlodipine besylate; olmesartan medoxomil (the active ingredients of Voltaren and Azor, respectively), and Voltaren and Azor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: